Home/Filings/4/0001062993-25-001085
4//SEC Filing

Klein Lawrence Otto 4

Accession 0001062993-25-001085

CIK 0000907654other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:41 PM ET

Size

5.6 KB

Accession

0001062993-25-001085

Insider Transaction Report

Form 4
Period: 2025-01-22
Klein Lawrence Otto
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-22+230,000230,000 total
    Exercise: $12.50Exp: 2035-01-21Common Stock (230,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.

Issuer

Oruka Therapeutics, Inc.

CIK 0000907654

Entity typeother

Related Parties

1
  • filerCIK 0001762583

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:41 PM ET
Size
5.6 KB